Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. May 7, 2006; 12(17): 2756-2761
Published online May 7, 2006. doi: 10.3748/wjg.v12.i17.2756
Published online May 7, 2006. doi: 10.3748/wjg.v12.i17.2756
Table 6 Comparison of global symptomatic improvement by age
| Age | Gastrex group | Cimetidine group | ||
| Improveed (%) | Not improved (%) | Improved (%) | Not improved (%) | |
| Less than fifty | 55 (61.8) | 14 (53.85) | 61 (63.54) | 12 (48.0) |
| fifty and over | 34 (38.2) | 12 (46.15) | 35 (36.46) | 13 (52.0) |
- Citation: Lee JH, Kim JJ, Hahm KB, Lee DH, Kim N, Kim SK, Park JJ, Choi SR, Lee JH, Lee ST, Lee EH, Rhee JC. Efficacy and safety of ecabet sodium on functional dyspepsia: A prospective, double-blinded, randomized, multi-center controlled trial. World J Gastroenterol 2006; 12(17): 2756-2761
- URL: https://www.wjgnet.com/1007-9327/full/v12/i17/2756.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i17.2756